HOME >> BIOLOGY >> NEWS
UNC-CH study indicates special vaccines could prevent insulin-dependent diabetes

Chapel Hill -- Results of a new University of North Carolina at Chapel Hill medical study suggest that vaccines can be made using plasmid DNA that would inhibit development of insulin-dependent diabetes, a growing health threat in the United States.

Plasmid DNA is circular genetic material obtained from bacteria. A chronic inflammatory disease, insulin-dependent diabetes, also called type I or juvenile onset diabetes, results from cells of the body's own immune system going awry and eventually killing other cells needed to produce insulin. In their experiments, UNC-CH researchers succeeded in preventing diabetes from starting in special laboratory mice that develop diabetes as they age. More importantly, the scientists say, they also halted progression of the illness in animals already affected.

" This work is very encouraging because it has the potential to be useful in clinical settings," said Dr. Roland Tisch, assistant professor of microbiology and immunology at the UNC-CH School of Medicine. "In the past, our group and others could manipulate the damaging auto-immune response in various animal models for type I diabetes but not in ways that would be readily feasible clinically."

A report on the research appears in the Feb. 1 issue of the Journal of Immunology. Besides Tisch, authors are Dr. Bo Wang, postdoctoral fellow; Dr. Donald J. Weaver, now a UNC-CH medical student; visiting scholar Dr. Bo Liu, Thi Bui, research assistant; Dr. James Arthos of the National Institutes of Health; and Dr. David V. Serreze, a researcher at Jackson Laboratory in Bar Harbor, Me.

"Recently, a Canadian group in Edmonton showed for the first time that islet beta cells -- the cells in the pancreas that produce insulin -- could be transplanted successfully in people with diabetes," Tisch said. "For more than a year, their patients have been free of insulin injections. A key issue, however, is that those individuals have had to take a cocktail of
'"/>

Contact: David Williamson
david_williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
30-Jan-2001


Page: 1 2

Related biology news :

1. Feds give $16 million to UNC-CH scientists studying waste site problems
2. UNC-CH study offers new evidence that garlic protects against cancers
3. UNC-CH researchers to study social effects of N.C. hurricane
4. UNC-CH experiments reveal new pen can disinfect water
5. UNC-CH bus brings mobile lab, high-tech science focus to underserved N.C. schools
6. UNC-CH researchers to comb N.C. mountains for iron problem chiefly affecting Scots, Irish
7. UNC-CH biologists identify new order of marine fungi
8. UNC-CH scientists create worlds smallest pieces of ice
9. UNC-CH scientist finds smallest number of genes needed for organisms survival
10. UNC-CH scientist encourages all to watch PBS series on microbes
11. Prestigious new nutrition research center being established at UNC-CH with NIH funding

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2019)... SCARBOROUGH, Maine (PRWEB) , ... ... ... instrumentation manufacturer Fluid Imaging Technologies ( http://www.fluidimaging.com ) announced today the release ... the FlowCam automated particle imaging and characterization platform will provide a significant ...
(Date:7/17/2019)... ... July 18, 2019 , ... ... Meredith James, HT, PMP, to its executive team as Vice President of Operations. ... drug development. In her new role, Ms. James is responsible for ensuring on-time ...
(Date:7/17/2019)... ... July 16, 2019 , ... At nearly eleven years ... legs. According to his owner, in the last year or so, he was ... His veterinarian, Dr. Cindy Echevarria of VCA University Animal Hospital in ...
Breaking Biology News(10 mins):
(Date:7/2/2019)... POWAY, Calif. (PRWEB) , ... July 02, 2019 , ... ... new documentary entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on ... and wild animals. Animal Pharm was recently included in the Brentwood ...
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
(Date:6/11/2019)... ... 2019 , ... Advancements with Ted Danson will focus on ... 4Q/2019. Check your local listings for more information. , Advancements will explore Bio-ITech ... facilitates laboratories to improve efficiency and quality of research by providing comprehensive and ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility for ... and Drug Branch for manufacturing. This is an important milestone for VetStem ...
Breaking Biology Technology:
Cached News: